Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Liu-Gen Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sci…. Hauptthemen laut MEDLINE: Lung Neoplasms, Artemisinins, Mitochondria, Pyroptosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Foundation of Health Commission of Hubei Province, Open Project of Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Project in Administration Bureau of Traditional Chinese Medicine of Hubei Province.
Abstract (Originalsprache)
Enhancement of malignant cell immunogenicity to relieve immunosuppression of lung cancer microenvironment is essential in lung cancer treatment. In previous study, we have demonstrated that dihydroartemisinin (DHA), a kind of phytopharmaceutical, is effective in inhibiting lung cancer cells and boosting their immunogenicity, while the initial target of DHA's intracellular action is poorly understood. The present in‐depth analysis aims to reveal the influence of DHA on the highly expressed TOM70 in the mitochondrial membrane of lung cancer. The affinity of DHA and TOM70 was analyzed by microscale thermophoresis (MST), pronase stability, and thermal stability. The functions and underlying mechanism were investigated using western blots, qRT‐PCR, flow cytometry, and rescue experiments. TOM70 inhibition resulted in mtDNA damage and translocation to the cytoplasm from mitochondria due to the disruption of mitochondrial homeostasis. Further ex and in vivo findings also showed that the cGAS/STING/NLRP3 signaling pathway was activated by mtDNA and thereby malignant cells underwent pyroptosis, leading to enhanced immunogenicity of lung cancer cells in the presence of DHA. Nevertheless, DHA‐induced mtDNA translocation and cGAS/STING/NLRP3 mobilization were synchronously attenuated when TOM70 was replenished. Finally, DHA was demonstrated to possess potent anti‐lung cancer efficacy in vitro and in vivo. Taken together, these data confirm that TOM70 is an important target for DHA to disturb mitochondria homeostasis, which further activates STING and arouses pyroptosis to strengthen immunogenicity against lung cancer thereupon. The present study provides vital clues for phytomedicine‐mediated anti‐tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China.
- Department of Pathology, Renmin Hospital of Shiyan, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Pathology, Shenzhen Pingle Orthopedic Hospital (Shenzhen Pingshan Traditional Chinese Medicine Hospital), Shenzhen, Guangzhou, China.
ORCID-Profile: Jun Hu, Tao Ren, Tong-Fei Li
Förderung
- Foundation of Health Commission of Hubei Province
- Open Project of Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine
- Project in Administration Bureau of Traditional Chinese Medicine of Hubei Province
- Excellent Young and Middle-aged Scientific and Technological Innovation Team of Universities of Hubei Province
- Innovative Research Program for Graduates of Hubei University of Medicine
- Advantages Discipline Group (Medicine) Project in Higher Education of Hubei Province
- National Natural Science Foundation of China
- Cultivating Project for Young Scholar at Hubei University of Medicine
Zitieren
APA
Li, L. G., Hu, J., Han, N., Chen, N. N., Yu, T. T., Ren, T., Xu, H. Z., Peng, X. C., Li, X. Y., Ma, T. Q., Chen, H., Zhang, L., Chen, X., Wang, M. F., & Li, T. F. (2024). Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer. Phytotherapy Research. https://doi.org/10.1002/ptr.8242
Vancouver
Li LG, Hu J, Han N, Chen NN, Yu TT, Ren T, et al. Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer. Phytotherapy Research. 2024. doi:10.1002/ptr.8242
BibTeX
@article{Li2024,
author = {Li, Liu-Gen and Hu, Jun and Han, Ning and Chen, Nan-Nan and Yu, Ting-Ting and Ren, Tao and Xu, Hua-Zhen and Peng, Xing-Chun and Li, Xian-Yu and Ma, Tian-Qi and Chen, Hao and Zhang, Lei and Chen, Xiao and Wang, Mei-Fang and Li, Tong-Fei},
title = {Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8242}
}
EUVIMED